ST. LOUIS (KMOX) – A local dermatologist says he’s excited by a new pill that treats skin cancer.
The new treatment, called Erivedge, is intended to treat advanced basil cell carcinoma for patients who are not candidates for surgery or radiation, and for patients whose cancer has spread to other parts of the body.
“It’s wonderful news,” according to Dr. Scott Fosko, chair of dermatology at St. Louis University School of Medicine. “Basil cell carcinoma is a very common skin cancer. Fortunately most of them present early and are very manageable. But we see many, many cancers that are quite advanced.”
He adds that they already have several patients that he believes would benefit from the use of Erivedge.
“So I do think it’s going to be a nice addition to our treatment,” he tells KMOX News, “and we look forward to seeing some good results, particularly in some of our severely-affected patients.”
The pill is taken once a day.
Basil cell carcinoma is the most common form of skin cancer.
KMOX © Copyright 2011 CBS Radio Inc. and its relevant subsidiaries. CBS RADIO and EYE Logo TM and Copyright 2011 CBS Broadcasting Inc. Used under license. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.